Similar Articles
881 Evolving role of Sorafenib in the management of hepatocellular carcinoma
882 Tenofovir induced severe thrombocytopenia
883 Spontaneous regression of hepatocellular carcinoma: A mini-review
884 Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients
885 Effect of NDC80 in human hepatocellular carcinoma
886 Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation
887 Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
888 Usefulness of the MESH score in a European hepatocellular carcinoma cohort
889 Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma
890 Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA